エピジェネティクス市場：製品、技術、手法、用途、エンドユーザー別-2024-2030年の世界予測

エピジェネティクス市場規模は2023年に37億1,000万米ドルと推定され、2024年には41億米ドルに達し、CAGR 10.82%で2030年には76億3,000万米ドルに達すると予測されています。

エピジェネティクスは、DNA配列の変化を伴わない遺伝性の表現型修飾の分析を指します。DNAやヒストンタンパク質に生じる化学的修飾を調べ、根本的な遺伝暗号を変えることなく遺伝子発現に影響を与えることができます。これらのエピジェネティックな変化は、年齢、環境、病気の状態など、いくつかの要因によって影響を受ける可能性があり、可逆的なメカニズムとして次世代に受け継がれます。エピジェネティクスは、遺伝子発現の制御に複雑なレイヤーを追加し、遺伝学、発生、遺伝の理解に重要な意味を持っています。エピジェネティクスの応用は、生物医学研究から治療的介入まで多岐にわたります。研究においては、エピジェネティクスは発生生物学と疾患の病因に関する洞察を提供します。臨床面では、がん治療、代謝異常、個別化医療に役立ちます。主なエンドユーザーは、学術・研究機関、製薬・バイオテクノロジー企業、診断センターなどです。エピジェネティクスに対するニーズは、世界の慢性疾患や遺伝性疾患の有病率の大幅な増加、創薬開発に対する政府の積極的な取り組みや投資、個別化医療への傾倒の高まりなどにより高まっています。しかし、エピジェネティクス技術の新興国市場は、開発コストの高さ、認知度の低さ、エピジェネティクスの適用範囲の狭さなどの課題に直面しており、エピジェネティクスの普及を妨げています。エピジェネティクスの進歩のための継続的な研究開発活動や、がん以外の分野でのエピジェネティクスの応用の拡大は、エピジェネティクスの発展の潜在的な機会を示しています。

製品エピジェネティック研究のための試薬・キットの使用増加

酵素は、DNAやヒストン上にメチル基などのエピジェネティックなマーカーを付加したり除去したりする役割を担っているため、エピジェネティック研究において極めて重要な役割を果たしています。DNAメチルトランスフェラーゼ（DNMT）やTET酵素などのDNA修飾酵素は、エピジェネティック修飾における重要なツールであり、DNAメチル化やヒドロキシメチル化パターンの研究に広く用いられています。ヒストンアセチルトランスフェラーゼ（HAT）、脱アセチル化酵素（HDAC）、メチルトランスフェラーゼ、脱メチル化酵素などのタンパク質修飾酵素は、ヒストンタンパク質を変化させ、クロマチン構造や遺伝子発現に影響を与えます。DNAシークエンサー、PCR増幅器、クロマチン剪断用ソニケーター、高度なイメージングシステムなど、エピジェネティック研究に必要なツールは、エピジェネティック修飾を解明するための基本です。これらの装置は、マイクロプレート、ピペット、ソフトウェアなどの重要なアクセサリーと組み合わされ、エピジェネティック現象の精密な解析を容易にします。エピジェネティック研究用に調整された試薬やキット（バイサルファイト変換キットやクロマチン免疫沈降キットなど）は、プロセスの合理化と標準化に役立ちます。5-hmCおよび5-mC分析キットは、DNAメチル化およびヒドロキシメチル化の検出と定量を簡素化します。メチル化シトシンや様々なヒストン修飾などのエピジェネティックマーカーに対する有効な抗体は、ウェスタンブロッティング、免疫蛍光、クロマチン免疫沈降（ChIP）などの技術に不可欠です。Bisulfite変換キットは、メチル化されていないシトシン残基をウラシルに変換し、シークエンシングやPCRによってメチル化DNAと非メチル化DNAの識別を可能にするもので、DNAメチル化研究の基礎となる手法です。ChIP-seqキットは、クロマチン免疫沈降の後にシーケンスを行うプロセスを効率化します。未修飾および翻訳後修飾のコアヒストンタンパク質とそのバリアントは、クロマチンリモデリングのin vitro研究や、特定の修飾が遺伝子発現にどのように影響するかを理解するために利用されます。全ゲノム増幅キットは、ナノグラム量のDNAをマイクログラムレベルまで増幅することを容易にし、単一細胞研究など開始材料が限られている場合のエピジェネティック解析に不可欠です。エピジェネティクスサービスには、DNAメチル化プロファイリング、ヒストン修飾マッピング、クロマチンアクセシビリティアッセイなどがあります。これらの専門的なサービスは、エピジェネティックデータの取得と解釈において研究者をサポートするために、バイサルファイトシーケンスなどの古典的な手法や次世代シーケンスのような最新のハイスループットメソッドを活用しています。エピジェネティクス研究では、解析に高度なバイオインフォマティクスツールを必要とする大規模なデータセットが得られます。ソフトウェア・ソリューションは、データ処理、可視化、統合プラットフォームを提供し、複雑なエピジェネティック・ネットワークの解読を可能にします。社内の能力が不足している研究機関や、高度に専門化された専門知識を求めている研究機関にとって、サービスはますます好まれるようになってきています。逆に、ソフトウェアは補完的な役割を果たし、データの量と複雑さが増すにつれて重要性が増しています。

技術ゲノムワイドなメチル化プロファイリングのための次世代シーケンサーの採用拡大

質量分析は、イオンの質量電荷比を推定する分析手法です。エピジェネティクス研究では、メチル化やアセチル化などのDNAやヒストンの変化を解析するために使用されます。この方法は非常に正確で、エピジェネティックなマークの小さな変化も検出することができます。研究者は、高い特異性と感度が必要な場合や複雑な混合物を扱う場合には、質量分析を好むかもしれないです。次世代シーケンシング（NGS）は、DNAとRNAのハイスループットなシーケンシングを可能にする強力な手法であり、ゲノム全体の遺伝的およびエピジェネティックなパターンを理解するために不可欠です。NGSは、ゲノムワイドなメチル化プロファイリング、クロマチン免疫沈降シーケンス（ChIP-seq）、転写レベルでのエピジェネティック変化を研究するためのRNAシーケンス（RNA-seq）などのエピジェネティックアプリケーションに使用できます。包括的なゲノムワイド解析が必要な場合や、エピジェネティックな変化が遺伝子発現に及ぼす影響を調べる場合には、NGSが望ましいです。定量的ポリメラーゼ連鎖反応（qPCR）およびポリメラーゼ連鎖反応（PCR）は、特定のDNA配列を増幅し定量するために使用される技術です。エピジェネティクスでは、これらの方法によって特定の遺伝子のメチル化状態を定量したり、エピジェネティック修飾に起因する遺伝子発現変化を測定することができます。PCRとqPCRは、広範でハイスループットなアプローチではなく、特定のDNAまたはRNA断片の標的分析に関心のある研究者によって使用されます。ソニケーションは、音のエネルギーを使って核酸やタンパク質をより小さな断片に分解する物理的剪断プロセスです。免疫沈降を行う前にクロマチンをせん断する必要があるChIP-seq法などのサンプル調製時に、エピジェネティクスでよく使用されます。ソニケーションは、DNAの均一な剪断が必要な場合、特にシーケンス研究の準備のために選択されます。さらに、これらのエピジェネティック解析技術の中から選択する場合、研究者はサンプルの性質、必要な分解能、必要とするデータの特異性と幅を考慮します。質量分析は特異性が高く、新規の変化や小さな変化を検出するのに理想的です。NGSは、全ゲノム解析のための包括的でハイスループットな機能を提供します。

方法X染色体不活性化におけるDNAメチル化の利用の増加

DNAメチル化はエピジェネティックな修飾技術であり、遺伝子プロモーターに位置する場合、遺伝子発現の抑制につながります。これは、胚発生、X染色体の不活性化、反復エレメントの抑制など、多様な生物学的プロセスにおいて重要な役割を果たしています。DNAメチル化解析は、初期発生段階や、インプリンティングやX染色体不活性化を伴う疾患を研究する際に好んで用いられます。DNAメチル化パターンを解析する技術には、バイサルファイトシークエンシング、メチル化特異的PCR（MSP）、アレイベースの方法などがあります。ヒストン修飾は、DNAが巻きついているヒストンタンパク質上で起こる。ヒストン上の様々なアミノ酸へのメチル、アセチル、リン酸、ユビキチンなどの化学基の付加や還元は、クロマチン構造や遺伝子活性に影響を与えます。例えば、アセチル化は一般に転写活性化に関連し、メチル化は特定のアミノ酸と付加されたメチル基の数によって、遺伝子発現を活性化したり抑制したりします。遺伝子制御、クロマチンダイナミクス、環境刺激に対する転写応答などの調査には、クロマチン免疫沈降法（ChIP）に続いて塩基配列を決定する方法（ChIP-seq）、質量分析に基づく方法、さまざまなヒストン修飾を認識する特異的抗体などが含まれるため、ヒストン修飾の研究が有利に働く。DNAメチル化とヒストン修飾は、遺伝子発現を駆動する複雑な制御ネットワークを理解する上で最も重要です。DNAメチル化解析は、発生生物学や疾患研究など、安定した長期的な遺伝子サイレンシングが重要な状況では不可欠です。対照的に、ヒストン修飾解析は、クロマチンと転写の変化をダイナミックに見ることができます。遺伝子発現の急激な変化や、環境因子がクロマチン構造に及ぼす影響を調べるのに特に有益です。

応用腫瘍学におけるエピジェネティックツールの応用の増加

心血管疾患（CVD）は、心臓関連の健康問題の世界の有病率の増加により、エピジェネティック研究の主要な焦点となっている分野です。DNAメチル化、ヒストン修飾、ノンコーディングRNA発現を含むエピジェネティックツールは、CVDの発症と進行に影響を及ぼすと考えられています。これらの修飾を理解することを目的とした研究は、早期発見や標的治療のための潜在的なバイオマーカーの同定につながる可能性があります。発生生物学はエピジェネティクス研究の重要な応用分野であり、エピジェネティクスの変化が胚発生から成人に至るまでの発生過程をどのように支配しているかを明らかにするものです。この分野の研究者は、エピジェネティック・プロファイルが発生過程でどのように変化し、変化すると発達障害を引き起こすのかに特に興味を持っています。免疫学では、エピジェネティクスは免疫応答の制御の理解と自己免疫疾患、アレルギー、炎症状態の治療の可能性に適用されます。この応用分野は、エピジェネティックなプロセスと免疫細胞の分化との相互作用の理解に大きく依存しています。その必要性は、現在の治療法に伴う副作用なしに免疫系の挙動を修正する新しい治療法の必要性によって推進されています。代謝性疾患におけるエピジェネティック研究は、肥満、糖尿病、その他の代謝症候群などの病態を対象としています。エピジェネティクスは、このような疾患の原因となる遺伝子と環境の相互作用を解読するために用いられます。この領域は、代謝プロファイルをリセットすることを目的としたバイオマーカー探索やエピジェネティックな薬剤開発のための実り多い場を提供します。がん発生におけるエピジェネティック修飾の役割を考えると、腫瘍学はエピジェネティクスの最も顕著な応用分野です。DNAメチル化およびヒストン修飾酵素を標的とするエピジェネティック薬剤はすでに使用されており、様々なタイプのがんに対して広範に調査しています。エピジェネティック腫瘍学的アプローチの必要性は、精密医療の必要性と世界のがんの高負担によって、計り知れないです。顕著なセグメントである腫瘍学は、がんに関連する死亡の影響が大きいため、多額の投資と研究が行われてきました。その結果、様々なエピジェネティック医薬品が着実に承認され、治療の強固なパイプラインが形成されています。

エンドユーザー：学術・研究機関からのエピジェネティックツールに対するニーズの高まり

学術・研究機関は、エピジェネティクスにおける基礎研究や発見の主要な場となっています。これらの機関は、次世代シーケンサー（NGS）、バイオインフォマティクスプラットフォーム、エピジェネティックキットや試薬などの高度な研究ツールを強く必要としています。ここでの焦点は、直接的な商業的応用よりも、エピジェネティックな変化のメカニズムや意味を理解することにあります。開発業務受託機関（CRO）は、様々なバイオテクノロジー、製薬、医療機器企業の第三者サービスプロバイダーとして活動しています。初期段階の調査から臨床試験、市販後のサポートまで、様々なサービスを提供しています。エピジェネティクスでは、CROは創薬・開発プロジェクトにおいて、ハイスループット機能と信頼性の高い検証サービスを提供する最先端技術を必要としています。CROは、製薬業界の厳しい規制基準に沿った、堅牢でスケーラブルなソリューションを好みます。製薬企業やバイオテクノロジー企業は、新薬や治療法の開発・商業化に携わっており、エピジェネティックな洞察に影響を受ける企業が増えています。これらの企業は、創薬、バイオマーカー開発、治療モニタリングを合理化できる包括的なエピジェネティック・プラットフォームを必要としています。製薬企業やバイオテクノロジー企業が好むのは、市場投入までのスピード、有効性、安全性を実現する統合ソリューションです。

地域別インサイト

北米のエピジェネティクス市場は、研究開発への多額の投資、製薬企業やバイオテクノロジー企業の強固な存在感、がんなどの慢性疾患の罹患率の高さなどから、主に米国が牽引して大きな成長を示しています。南米では、エピジェネティクスの採用は初期段階にあり、遺伝性疾患やガンの有病率の増加により発展の可能性があります。ブラジルは、進化するヘルスケア部門と高度な治療に対する国民の意識の高まりにより、エピジェネティクスの発展をサポートしています。APAC地域は、中国、日本、インドなどの新興経済国により、エピジェネティクス分野で急速な転換期を迎えています。中国では特許出願が急増しており、エピジェネティクスに対する政府や民間の関心が高いことを示しています。日本政府は精密医療を奨励し、その結果エピジェネティック研究プログラムへの資金が増加しています。インドのエピジェネティック研究への参加は拡大しており、共同研究や研究の数が増加しています。欧州のエピジェネティクス市場は、ドイツ、英国、フランスなどの国々が牽引して堅調です。広範な研究活動、確立されたヘルスケアシステム、民間および公的セクターからの投資拡大がこの地域の発展を後押ししています。さらに、主要企業と学術機関の活発な協力関係が、先進的なエピジェネティック療法の開発を支えています。中東地域では、がんなどの有病率の上昇やヘルスケアインフラの拡大により、エピジェネティクスが徐々に進展しています。個別化医療への関心が着実に高まり、購買パターンに影響を与えています。アフリカでは、エピジェネティクスの開発は初期段階にあり、研究施設も限られています。しかし、ヘルスケア調査における国際的な協力の増加により、拡大の可能性があります。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはエピジェネティクス市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、エピジェネティクス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.エピジェネティクス市場の市場規模および予測は？

2.エピジェネティクス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.エピジェネティクス市場の技術動向と規制枠組みは？

4.エピジェネティクス市場における主要ベンダーの市場シェアは？

5.エピジェネティクス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患および遺伝性疾患の有病率が著しく増加している
    • 医薬品の発見と開発に対する政府の好ましい取り組みと投資
    • パーソナライズ医療への傾向の高まり
  • 抑制要因
    • エピジェネティクス技術の開発コストが高い
  • 機会
    • エピジェネティクスの発展に向けた継続的な研究開発活動
    • エピジェネティクスの非腫瘍学分野への応用拡大
  • 課題
    • エピジェネティクスの認識不足と適用の制限
• 市場セグメンテーション分析
  • 製品：エピジェネティクス調査用試薬およびキットの使用増加
  • 技術：ゲノムワイドメチル化プロファイリングのための次世代シーケンシングの採用拡大
  • 方法：X染色体不活性化におけるDNAメチル化の利用増加
  • 応用：腫瘍学におけるエピジェネティックツールの応用の増加
  • エンドユーザー：学術機関や調査機関からのエピジェネティックツールの需要の高まり
• 市場動向分析
  • 南北アメリカ地域に大手企業が参入し、臨床・農業分野への応用と技術の進歩に向けた継続的なエピジェネティクス調査を実施
  • アジア太平洋地域では高齢化人口の増加に伴い研究開発活動が活発化している
  • EMEA地域における環境と農業への応用に関連する高度なヘルスケアインフラと強力なエピジェネティクス調査活動
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 エピジェネティクス市場：製品別

• 酵素
• 楽器とアクセサリー
• 試薬とキット
• サービス
• ソフトウェア

第7章 エピジェネティクス市場：技術別

• 質量分析
• 次世代シーケンシング
• ポリメラーゼ連鎖反応と定量的ポリメラーゼ連鎖反応
• 超音波処理

第8章 エピジェネティクス市場方法別

• DNAメチル化
• ヒストンの修飾

第9章 エピジェネティクス市場：用途別

• 心血管疾患
• 発生生物学
• 免疫学
• 代謝性疾患
• 腫瘍学

第10章 エピジェネティクス市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのエピジェネティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のエピジェネティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのエピジェネティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ゼニスとセンコラが提携し、ZEN-3694プログラムを加速
  • FOXO、DataRobotと提携してAIベースのエピジェネティックバイオマーカー調査を実施
  • Zymo調査とOpentronsが提携し、新しい無細胞DNA分離化学を自動化
  • MSUの生化学者が自閉症スペクトラム障害のエピジェネティック調査のためにNIHから280万米ドルの助成金を獲得
  • アジレント、がん調査向け高性能NGSターゲットエンリッチメントワークフローの開発会社Avida Biomedの買収を発表
  • アストラゼネカはパイプラインを前進させ、AACRで免疫腫瘍学、ADC、細胞療法、エピジェネティクスの進歩を強調
  • バイオモーダルが遺伝学とエピジェネティクスソリューションをリリース
  • クロマ・メディシンがエピジェネティック編集に注力
  • イプセンがエピザイムを買収、腫瘍学のポートフォリオを拡大
  • ゼニスエピジェネティクス、国立がん研究所（NCI）が後援する複数の腫瘍臨床試験の開始を発表

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
• FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. EPIGENETICS MARKET DYNAMICS
• FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 76. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 77. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 78. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 79. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 80. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 83. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 84. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 85. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 88. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 89. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 90. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 91. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 92. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 93. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 94. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 95. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 96. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 97. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 98. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 99. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 100. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 101. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 104. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 105. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 106. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 107. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 108. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 109. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 110. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 111. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 112. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 113. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 114. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 115. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 116. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 117. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 118. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 119. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 120. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 121. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 122. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 123. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 124. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 125. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 126. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 127. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 128. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 129. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 132. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 133. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 134. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 135. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 136. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 137. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 138. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 139. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 140. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 141. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 142. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 143. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 146. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 147. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 148. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 149. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 150. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 151. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 152. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 153. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 154. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 155. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 156. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 157. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 160. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 161. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 162. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 163. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 164. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 165. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 166. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 168. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 170. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 171. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 172. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 173. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 174. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 175. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 176. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 177. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 178. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 179. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 180. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 181. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 182. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 183. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 184. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 185. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 186. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 187. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 188. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 189. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 192. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 193. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 196. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 197. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 198. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 199. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 200. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 201. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 202. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 203. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 206. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 207. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 208. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 209. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 210. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 211. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 212. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 213. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 214. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 215. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 216. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 217. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 220. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 221. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 222. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 223. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 224. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 225. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 226. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 227. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 228. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 229. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 230. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 231. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 234. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 235. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 238. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 239. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 240. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 241. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 242. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 243. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 244. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 245. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 246. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 247. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 248. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 249. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 250. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 251. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 252. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 253. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 254. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 255. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 256. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 257. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 258. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 259. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 260. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 261. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 262. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 263. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 264. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 265. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 266. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 267. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 268. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 269. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 270. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 271. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 272. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 273. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 276. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 277. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 278. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 279. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 280. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 281. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 282. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 283. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 284. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 285. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 286. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 287. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 288. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 289. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 290. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 291. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 292. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 293. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 294. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 296. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 297. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 298. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 299. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 300. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 301. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 302. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 303. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 304. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 305. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 306. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 307. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 308. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 309. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 310. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 311. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 312. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 313. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 314. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 315. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 316. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 317. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 318. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 319. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 320. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 321. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 322. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 323. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 324. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 325. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 326. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 327. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 328. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 329. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 330. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 331. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 332. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 333. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 334. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 335. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 336. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 337. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 338. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 339. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 340. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 341. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 342. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 343. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 344. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 345. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 346. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 347. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 348. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 349. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 350. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 351. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 352. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 353. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 354. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 355. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 356. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 357. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 358. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 359. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 360. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 361. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 362. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 363. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 364. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 365. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 366. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
• TABLE 367. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
• TABLE 368. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
• TABLE 369. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
• TABLE 370. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
• TABLE 371. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
• TABLE 372. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
• TABLE 373. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 374. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 375. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 376. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 377. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 378. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 379. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
• TABLE 380. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)

TABL

[190 Pages Report] The Epigenetics Market size was estimated at USD 3.71 billion in 2023 and expected to reach USD 4.10 billion in 2024, at a CAGR 10.82% to reach USD 7.63 billion by 2030.

Epigenetics refers to the analysis of heritable phenotype modifications that do not involve alterations in the DNA sequence. It examines the chemical modifications that occur on DNA and histone proteins, which can affect gene expression without changing the underlying genetic code. These epigenetic changes can be influenced by several factors, including age, environment, and disease state, and they are reversible mechanisms passed down to subsequent generations. Epigenetics provides an additional layer of complexity to the regulation of gene expression, and it has significant implications for our understanding of genetics, development, and inheritance. Applications of epigenetics span from biomedical research to therapeutic interventions. In research, epigenetics offers insights into developmental biology and the etiology of diseases. Clinically, it has implications in cancer treatment, metabolic disorders, and personalized medicine. The primary end-users include academic & research institutes, pharmaceutical & biotech companies, and diagnostic centers. The need for epigenetics is increasing due to substantial growth in the prevalence of chronic and genetic disorders worldwide, favorable governmental initiatives and investments in drug discovery and development, and a growing inclination toward personalized medicines. However, the market faces certain challenges, including the high cost of developing epigenetics technologies, lack of awareness, and limited application of epigenetics, hindering the adoption of epigenetics. Ongoing research and development activities for the advancement of epigenetics and expanding the application of epigenetics in non-oncology fields present potential opportunities for the development of epigenetics.

Product: Increasing usage of reagents & kits for epigenetic research

Enzymes play a pivotal role in epigenetic research, as they are responsible for adding or removing epigenetic markers such as methyl groups on DNA or histones. DNA-modifying enzymes, such as DNA methyltransferases (DNMTs) and TET enzymes, are crucial tools in epigenetic modification, widely used in research to study DNA methylation and hydroxymethylation patterns. Protein-modifying enzymes such as histone acetyltransferases (HATs), deacetylases (HDACs), methyltransferases, and demethylases alter histone proteins, influencing chromatin structure and gene expression. The tools necessary for epigenetic research, such as DNA sequencers, PCR amplifiers, sonicators for chromatin shearing, and advanced imaging systems, are fundamental to elucidating epigenetic modifications. These instruments, paired with essential accessories such as microplates, pipettes, and software, facilitate the precise analysis of epigenetic phenomena. Reagents and kits tailored for epigenetic research, which include bisulfite conversion kits or chromatin immunoprecipitation kits, serve to streamline and standardize processes. 5-hmC & 5-mC analysis kits simplify detecting and quantifying DNA methylation and hydroxymethylation. Validated antibodies against epigenetic markers such as methylated cytosine or various histone modifications are indispensable for techniques such as western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP). Bisulfite conversion kits convert unmethylated cytosine residues to uracil, which enables the discrimination of methylated from unmethylated DNA via sequencing or PCR, serving as a cornerstone method in DNA methylation studies. ChIP-seq kits streamline the process of performing chromatin immunoprecipitation followed by sequencing. Unmodified and post-translationally modified core histone proteins and their variants are utilized for in vitro studies of chromatin remodeling and to understand how specific modifications influence gene expression. Whole genome amplification kits facilitate the amplification of nanogram quantities of DNA to microgram levels, which is essential for epigenetic analysis when starting material is limited, such as in single-cell studies. Epigenetics services include DNA methylation profiling, histone modification mapping, and chromatin accessibility assays. These specialized services leverage classic techniques, such as bisulfite sequencing, and modern high-throughput methods, such as next-generation sequencing, to support researchers in epigenetic data acquisition and interpretation. Epigenetics research yields large datasets that necessitate sophisticated bioinformatics tools for analysis. Software solutions provide data processing, visualization, and integration platforms, enabling the decoding of complex epigenetic networks. Services are increasingly becoming preferred for research entities lacking in-house capabilities or those looking for highly specialized expertise. Conversely, the software serves a complementary role, growing in importance as the volume and complexity of data escalate.

Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling

Mass spectrometry is an analytical method that estimates the mass-to-charge ratio of ions. It is used in epigenetic studies to analyze DNA and histone changes, such as methylation and acetylation. The method is very precise, allowing for the detection of even small changes in epigenetic marks. Researchers may prefer mass spectrometry when they require high specificity and sensitivity or deal with complex mixtures. Next-generation sequencing (NGS) is a powerful method that allows for high-throughput sequencing of DNA and RNA, which is critical for understanding genetic and epigenetic patterns across the genome. NGS can be used for epigenetic applications such as genome-wide methylation profiling, chromatin immunoprecipitation sequencing (ChIP-seq), and RNA sequencing (RNA-seq) to study epigenetic changes at the transcriptional level. NGS is preferred when comprehensive, genome-wide analysis is required or while examining the effects of epigenetic changes on gene expression. Quantitative polymerase chain reaction (qPCR)and polymerase chain reaction (PCR) are techniques used to amplify and quantify specific DNA sequences. In epigenetics, these methods can quantify the methylation status of particular genes or measure gene expression changes resulting from epigenetic modification. PCR and qPCR are used by researchers that are interested in targeted analysis of specific DNA or RNA fragments rather than a broad, high-throughput approach. Sonication is a physical shearing process that uses sound energy to break nucleic acids and proteins into smaller fragments. It is often used in epigenetics during the preparation of samples for methods such as ChIP-seq, where chromatin must be sheared before immunoprecipitation can occur. Sonication is selected when uniform shearing of DNA is necessary, particularly in preparation for sequencing studies. Moreover, when choosing among these epigenetic analysis techniques, researchers consider the nature of their sample, the resolution needed, and the specificity and breadth of data they require. Mass spectrometry offers high specificity, making it ideal for detecting novel or small changes. NGS presents comprehensive and high-throughput capabilities for whole-genome analysis.

Methods: Rising utilization of DNA methylation for X-chromosome inactivation

DNA methylation is an epigenetic modification technique that leads to the repression of gene expression when located in gene promoters. It plays a critical role in diverse biological processes such as embryonic development, X-chromosome inactivation, and suppression of repetitive elements. DNA methylation analysis is preferred when studying early developmental stages and diseases that involve imprinting or X-chromosome inactivation. Techniques utilized for analyzing DNA methylation patterns include bisulfite sequencing, methylation-specific PCR (MSP), and array-based methods. Histone modifications occur on the histone proteins around which DNA is wound. The addition or reduction of chemical groups such as methyl, acetyl, phosphate, and ubiquitin to various amino acids on histones can affect chromatin structure and gene activity. Acetylation, for instance, is generally associated with transcriptional activation, while methylation can activate or suppress gene expression, relying on the specific amino acid and the number of methyl groups added. Research in gene regulation, chromatin dynamics, and transcriptional response to environmental stimuli can favor histone modification studies as it includes chromatin immunoprecipitation (ChIP) followed by sequencing (ChIP-seq), mass spectrometry-based methods and specific antibodies that recognize various histone modifications. DNA methylation and histone modifications are paramount for understanding the complex regulatory networks that drive gene expression. DNA methylation analyses are indispensable in certain contexts, such as developmental biology and disease studies where stable, long-term gene silencing is crucial. In contrast, histone modification analyses offer a dynamic view of chromatin and transcriptional changes. They are particularly beneficial for investigating rapid gene expression changes and the effects of environmental factors on chromatin structure.

Application: Increasing application of epigenetic tools in oncology

Cardiovascular diseases (CVDs) are a major area of focus for epigenetic research due to the increasing prevalence of heart-related health issues globally. Epigenetic tools, including DNA methylation, histone modification, and non-coding RNA expression, are believed to influence the development and progression of CVDs. Studies aimed at understanding these modifications could lead to identifying potential biomarkers for early detection and targeted therapies. Developmental biology is a critical application for epigenetic research, illuminating how epigenetic changes govern development processes from embryogenesis to adulthood. Researchers in this field are particularly interested in the way epigenetic profiles change during development, and they can result in developmental disorders when altered. In immunology, epigenetics applies to understanding the regulation of immune response and the potential to treat autoimmune diseases, allergies, and inflammatory conditions. The application segment relies heavily on understanding the interaction between epigenetic processes and immune cell differentiation. The need is propelled by the need for new therapeutic methods that modify immune system behavior without the adverse effects associated with current treatments. Epigenetic research in metabolic diseases targets conditions such as obesity, diabetes, and other metabolic syndromes. Epigenetics is used to decipher the gene-environment interactions contributing to such diseases. This arena provides fruitful ground for biomarker discovery and epigenetic drug development aimed at resetting metabolic profiles. Oncology is the most prominent application of epigenetics, given the role of epigenetic modifications in cancer development. Epigenetic drugs targeting DNA methylation and histone modification enzymes are already in use and are being studied extensively for various types of cancers. The need for epigenetic oncology approaches is immense, driven by the need for precision medicine and the high burden of cancer worldwide. Oncology, as a prominent segment, has witnessed significant investment and research due to the high impact of cancer-related deaths. It has steadily resulted in various approved epigenetic drugs and a robust pipeline of therapies.

End-User: Growing need for epigenetic tools from academic & research institutes

Academic and research institutes serve as primary grounds for basic research and discovery in epigenetics. These institutions strongly need advanced research tools such as next-generation sequencing (NGS), bioinformatics platforms, and epigenetic kits and reagents. The focus here is largely on understanding the mechanisms and implications of epigenetic changes rather than immediate commercial applications. Contract research organizations (CROs) operate as third-party service providers for various biotechnology, pharmaceutical, and medical device companies. They perform various services, from early-stage research to clinical trials and post-market support. In epigenetics, CROs need cutting-edge technologies that offer high-throughput capabilities and reliable validation services for drug discovery and development projects. CROs prefer robust, scalable solutions aligned with the pharmaceutical industry's stringent regulatory standards. Pharmaceutical and biotechnology companies are involved in developing and commercializing new drugs and treatments and an increasing number of these companies are being influenced by epigenetic insights. These companies require comprehensive epigenetic platforms that can streamline drug discovery, biomarker development, and therapeutic monitoring. The preference for pharma and biotech is for integrated solutions that deliver speed to market, efficacy, and safety.

Regional Insights

The epigenetics market in North America has exhibited substantial growth, primarily driven by the United States, attributed to heavy investments in research and development, the robust presence of pharmaceutical and biotechnology companies, and a high incidence rate of chronic diseases such as cancer. In South America, the adoption of epigenetics is in the nascent stage and has a potential for development due to the increasing prevalence of genetic disorders and cancers, and Brazil supports the development of epigenetics with an evolving healthcare sector and growing public awareness about advanced treatments. The APAC region is undergoing a rapid transition in the epigenetics sector due to emerging economies such as China, Japan, and India. China has witnessed a surge in patent filings, indicating strong governmental and private interest in epigenetics. The Japanese government encourages precision medicine, resulting in increased funding for epigenetic research programs. India's participation in epigenetic research is expanding, with an increasing number of collaborations and studies. Europe's epigenetics market is robust, led by countries such as Germany, the UK, and France. Extensive research activities, well-established healthcare systems, and growing investments from the private and public sectors propel the regional development. Additionally, active collaborations between key players and academic institutions support the development of advanced epigenetic therapies. The Middle East region is experiencing gradual progress in epigenetics due to the rising prevalence of conditions such as cancer and the expansion of healthcare infrastructure. The interest in personalized medicine is steadily gaining traction, influencing purchasing patterns. In Africa, the development of epigenetics is in the early stages, with limited research facilities. However, there is potential for expansion with increasing international collaboration in healthcare research.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Epigenetics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Epigenetics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Active Motif, Inc., Agilent Technologies, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., BioCat GmbH by AddLife AB, Bioneer Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Cambridge Epigenetix Ltd., Chroma Medicine, Inc., Creative Biogene, Creative Diagnostics, Cusabio Technology LLC, Diagenode S.A. by Hologic, Inc., Elysium Health, Inc., EpiCypher, Inc., Epigenic Therapeutics, EpiGentek Group Inc., Eurofins Scientific SE, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fios Genomics Ltd., FOXO Technologies Inc., GenomeScan, GenScript Biotech Corporation, Gilead Sciences, Inc., Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Ipsen, Lonza Group Ltd., Merck KGaA, MorphoSys AG, New England Biolabs, Inc., Novogene Co, Ltd., Omega Therapeutics, Inc., Pacific Biosciences of California, Inc, PerkinElmer, Inc., Promega Corporation, ProteoGenix SAS, Qiagen N.V., Sound Agriculture Company, STORM Therapeutics LTD, Takara Holdings Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Watchmaker Genomics, Inc., Zenith Epigenetics Ltd., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Enzymes
    • DNA-Modifying Enzymes
    • Protein-Modifying Enzymes

• Instruments & Accessories
• Reagents & Kits
  • 5-hmC & 5-mC Analysis Kit
  • Antibodies
  • Bisulfite Conversion Kits
  • ChiP-seq Kits
  • Histones
  • Whole Genome Amplification Kits

• Service
• Software

• Technique
  • Mass Spectrometry
  • Next-Generation Sequencing
  • Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
  • Sonication

• Methods
  • DNA Methylation
  • Histone Modifications

• Application
  • Cardiovascular Diseases
  • Developmental Biology
  • Immunology
  • Metabolic Diseases
  • Oncology

• End User
  • Academic & Research Institutes
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Epigenetics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Epigenetics Market?

3. What are the technology trends and regulatory frameworks in the Epigenetics Market?

4. What is the market share of the leading vendors in the Epigenetics Market?

5. Which modes and strategic moves are suitable for entering the Epigenetics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
    • 5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
    • 5.1.1.3. Growing inclination toward personalized medicines
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of epigenetics technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
    • 5.1.3.2. Expanding the application of epigenetics in non-oncology fields
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness and limited application of epigenetics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
  • 5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
  • 5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
  • 5.2.4. Application: Increasing application of epigenetic tools in oncology
  • 5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
• 5.3. Market Trend Analysis
  • 5.3.1. Continuous epigenetics research for clinical and agricultural applications and technological advancements with a presence of major players in the Americas region
  • 5.3.2. Increasing research and development activities coupled with growing geriatric population in the APAC region
  • 5.3.3. Advanced healthcare infrastructure and strong epigenetics research activities associated with environment and agricultural applications in the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Epigenetics Market, by Product

• 6.1. Introduction
• 6.2. Enzymes
• 6.3. Instruments & Accessories
• 6.4. Reagents & Kits
• 6.5. Service
• 6.6. Software

7. Epigenetics Market, by Technique

• 7.1. Introduction
• 7.2. Mass Spectrometry
• 7.3. Next-Generation Sequencing
• 7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
• 7.5. Sonication

8. Epigenetics Market, by Methods

• 8.1. Introduction
• 8.2. DNA Methylation
• 8.3. Histone Modifications

9. Epigenetics Market, by Application

• 9.1. Introduction
• 9.2. Cardiovascular Diseases
• 9.3. Developmental Biology
• 9.4. Immunology
• 9.5. Metabolic Diseases
• 9.6. Oncology

10. Epigenetics Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Epigenetics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Epigenetics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Epigenetics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
  • 14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
  • 14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
  • 14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
  • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
  • 14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
  • 14.3.7. Biomodal Releases Genetics And Epigenetics Solution
  • 14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
  • 14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
  • 14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio